Diagnostic value of combining PI-RADS v2.1 with PSAD in clinically significant prostate cancer

Cancer treatment and survivorship statistics, 2019

Kimberly D. Miller, Letícia Nogueira, Angela B. Mariotto et al. · CA A Cancer Journal for Clinicians · 2019 · 4.4K citations · Full text

Medicine, Oncology, Population Health Sciences +17

Pathologic and Clinical Findings to Predict Tumor Extent of Nonpalpable (Stage T1 c) Prostate Cancer

Jonathan I. Epstein · JAMA · 1994 · 1.8K citations

Medicine, Surgery, Urology +17

Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer

Laurence Klotz, Danny Vesprini, Perakaa Sethukavalan et al. · Journal of Clinical Oncology · 2014 · 1.2K citations · Full text

Medicine, Oncology, Urology +15

Prostate Specific Antigen Density: A Means of Distinguishing Benign Prostatic Hypertrophy and Prostate Cancer

Mitchell C. Benson, Ihn Seong Whang, Allan J. Pantuck et al. · The Journal of Urology · 1992 · 773 citations

Medicine, Oncology, Urology +17

JAPANESE JOURNAL OF CLINICAL ONCOLOGY

JNCI Journal of the National Cancer Institute · 2011 · 304 citations · Full text

Medicine, Clinical Sciences, Oncology +5